INTERLEUKIN-10 PRODUCTION DURING SEPTICEMIA

被引:297
作者
MARCHANT, A
DEVIERE, J
BYL, B
DEGROOTE, D
VINCENT, JL
GOLDMAN, M
机构
[1] UNIV LIBRE BRUXELLES,HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
[2] UNIV LIBRE BRUXELLES,HOP ERASME,DEPT GASTROENTEROL,B-1070 BRUSSELS,BELGIUM
[3] UNIV LIBRE BRUXELLES,HOP ERASME,DEPT INFECT DIS,B-1070 BRUSSELS,BELGIUM
[4] UNIV LIBRE BRUXELLES,HOP ERASME,INTENS CARE UNIT,B-1070 BRUSSELS,BELGIUM
[5] MEDGENIX GRP,DEPT RES & DEV,FLEURUS,BELGIUM
关键词
D O I
10.1016/S0140-6736(94)91584-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-10 is produced during incubation of human whole blood with bacterial lipopolysaccharide (LPS) and down-regulates tumour necrosis factor-alpha production in this in-vitro model of endotoxaemia. 39 out of 69 (57%) patients with gram-negative (n = 25) or gram-positive septicaemia (n = 44) had increased plasma interleukin-10 (range 12-2740 pg/mL), whereas interleukin-10 was undetectable in 29 out of 33 control patients without infection and in 20 healthy volunteers. Patients with septic shock (n = 21) had higher interleukin-10 (median 58 pg/mL) than septicaemic patients without shock (11 pg/mL, p<0.001). We conclude that interleukin-10 is produced during sepsis and might be involved in the control of the inflammatory response induced by bacterial products.
引用
收藏
页码:707 / 708
页数:2
相关论文
共 8 条
[1]   MACROPHAGE DEACTIVATION BY INTERLEUKIN-10 [J].
BOGDAN, C ;
VODOVOTZ, Y ;
NATHAN, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06) :1549-1555
[2]   INVIVO INDUCTION OF INTERLEUKIN-10 BY ANTI-CD3 MONOCLONAL-ANTIBODY OR BACTERIAL LIPOPOLYSACCHARIDE - DIFFERENTIAL MODULATION BY CYCLOSPORINE-A [J].
DUREZ, P ;
ABRAMOWICZ, D ;
GERARD, C ;
VANMECHELEN, M ;
AMRAOUI, Z ;
DUBOIS, C ;
LEO, O ;
VELU, T ;
GOLDMAN, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :551-555
[3]   INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA [J].
GERARD, C ;
BRUYNS, C ;
MARCHANT, A ;
ABRAMOWICZ, D ;
VANDENABEELE, P ;
DELVAUX, A ;
FIERS, W ;
GOLDMAN, M ;
VELU, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :547-550
[4]   SEPTIC SHOCK - PATHOGENESIS [J].
GLAUSER, MP ;
ZANETTI, G ;
BAUMGARTNER, JD ;
COHEN, J .
LANCET, 1991, 338 (8769) :732-736
[5]   INTERLEUKIN-10 PROTECTS MICE FROM LETHAL ENDOTOXEMIA [J].
HOWARD, M ;
MUCHAMUEL, T ;
ANDRADE, S ;
MENON, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (04) :1205-1208
[6]   MODIFIED IMMUNOLOGICAL STATUS OF ANTI-IL-10 TREATED MICE [J].
ISHIDA, H ;
HASTINGS, R ;
THOMPSONSNIPES, L ;
HOWARD, M .
CELLULAR IMMUNOLOGY, 1993, 148 (02) :371-384
[7]  
MALEFYT RD, 1991, J EXP MED, V174, P1209
[8]   INTERLEUKIN-10 INHIBITS THE INDUCTION OF MONOCYTE PROCOAGULANT ACTIVITY BY BACTERIAL LIPOPOLYSACCHARIDE [J].
PRADIER, O ;
GERARD, C ;
DELVAUX, A ;
LYBIN, M ;
ABRAMOWICZ, D ;
CAPEL, P ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) :2700-2703